


Atorvia
Biotechnology Research • SpinUp Lab, University of Toronto at Mississauga, Canada • 1-10 Employees
Company overview
| Headquarters | SpinUp Lab, University of Toronto at Mississauga, Canada |
| Website | |
| NAICS | 541714 |
| Keywords | Peptides, CKD, Acute Kidney Injury, Organ Failure, Regulated Cell Death |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contact at Atorvia
David Allinson
Co-Founder, Cbo & Cfo
Atorvia Email Formats
Atorvia uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@atorvia.co), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@atorvia.co | 100% |
About Atorvia
Atorvia is a pre-clinical stage biotech company leveraging proteomics, AI tools and biomarker insights to develop and advance a pipeline of therapies to prevent and treat kidney failure. Headquartered in Ontario, Canada, Atorvia is uncovering potential new ways of diagnosing, preventing and treating kidney disease.
Atorvia revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Atorvia has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Atorvia has never raised funding before.
Atorvia Tech Stack
Discover the technologies and tools that power Atorvia's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
JavaScript libraries
CMS
Performance
Frequently asked questions
4.8
40,000 users



